Upload File

indian immunodiagnostics market to grow at a cagr of 11% in the next five years

  • Home
  • Business
  • Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years
5
Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years Driven by factors such as increasing popularity in preliminary testing, portability and ease of use; the market for Immunodiagnostics is expected to grow robustly in the coming years. IMARC Group, one of the world's leading research and advisory firms, in its latest report entitled “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” expects the market for immunodiagnostics in India to grow at a CAGR of 11% during 2011-16. Findings from the report suggested that immunology based diagnostics currently provide numerous advantages over other diagnostic technologies. The time, duration and costs currently involved with immunodiagnostics, and in particular, the rapid tests are ideal for conducting preliminary tests. Immunology based tests offer a significantly higher sensitivity compared to microscopy based tests and are significantly more economical and easier to use than the PCR based tests which are currently mainly used as confirmatory tests. Apart from their popularity in preliminary testing, the report also found that most rapid immunodiagnostic tests also offer other advantages such as portability and ease of use. Some of the rapid tests are highly portable and can be easily conducted anywhere without the requirements of sophisticated labs, equipment, electricity or trained technicians. For instance, around 70% of the total pregnancy tests are currently being conducted at home without the requirement of a lab or a trained technician. Despite its strong growth, the report also noted that factors such as decreasing prices, short product lifecycles and high dependency on imports were major factors hampering the growth of this market. The report found that a major cause of concern was the increasing imports from China, with Chinese manufacturers selling their kits at significantly lower prices than that of domestic manufacturers. imarc © 1

Upload: imarc-group

Post on 18-Jan-2015

472 views

Category:

Business


1 download

Report

DESCRIPTION

Driven by factors such as increasing popularity in preliminary testing, portability and ease of use; the market for Immunodiagnostics is expected to grow robustly in the coming years.

TRANSCRIPT

Page 1: Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

Indian Immunodiagnostics Market to Grow at a CAGR of

11% in the Next Five Years

Driven by factors such as increasing popularity in preliminary testing, portability

and ease of use; the market for Immunodiagnostics is expected to grow robustly in

the coming years.

IMARC Group, one of the world's leading research and advisory firms, in its latest report

entitled “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast:

2011-2016” expects the market for immunodiagnostics in India to grow at a CAGR of 11%

during 2011-16. Findings from the report suggested that immunology based diagnostics

currently provide numerous advantages over other diagnostic technologies. The time,

duration and costs currently involved with immunodiagnostics, and in particular, the rapid

tests are ideal for conducting preliminary tests. Immunology based tests offer a significantly

higher sensitivity compared to microscopy based tests and are significantly more

economical and easier to use than the PCR based tests which are currently mainly used as

confirmatory tests. Apart from their popularity in preliminary testing, the report also found

that most rapid immunodiagnostic tests also offer other advantages such as portability and

ease of use. Some of the rapid tests are highly portable and can be easily conducted

anywhere without the requirements of sophisticated labs, equipment, electricity or trained

technicians. For instance, around 70% of the total pregnancy tests are currently being

conducted at home without the requirement of a lab or a trained technician.

Despite its strong growth, the report also noted that factors such as decreasing prices, short

product lifecycles and high dependency on imports were major factors hampering the

growth of this market. The report found that a major cause of concern was the increasing

imports from China, with Chinese manufacturers selling their kits at significantly lower prices

than that of domestic manufacturers.

IMARC’s new report entitled “Indian Diagnostic & Therapeutic Antibodies Market

Report & Forecast: 2011-2016” provides an analytical and statistical insight into the

Indian Antibodies market. The study, that has been undertaken using desk-based as well as

qualitative primary research, provides and draws upon analysis of the following aspects of

the Indian antibodies market.

Key Aspects Analyzed:

imarc© 1

Page 2: Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

Diagnostic Antibodies

Understanding the strengths, weaknesses, opportunities and challenges in the

Indian diagnostic antibodies market

Understanding the technological considerations and regulatory factors in the

Indian diagnostic antibodies market

Evaluating the various types of antibody based diagnostic tests conducted in India

and analyzing their strengths and weaknesses.

Understanding the key regulations for registering, manufacturing and importing

diagnostics in India.

Comprehensive situation analysis of the Indian diagnostic antibodies market

Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and

Oncology

Focus of the analysis in each segment:

Number of tests conducted each year

Breakup by type of tests conducted

Current and future market sales

Average cost of diagnostic tests

Key players operating in the market

Therapeutic Antibodies

Understanding the strengths, weaknesses, opportunities and challenges in the

Indian therapeutic antibodies market

Understanding the technological considerations and regulatory factors in the

Indian therapeutic antibodies market

Evaluation and identification of monoclonal antibodies based on the sources from

which they are derived and on the targets against which they act.

Understanding the key regulations for registering, manufacturing and importing

therapeutic antibodies in India.

Evaluating the patent details of all globally marketed monoclonal antibodies in

India, US and Europe

Identifying the patentee name and patent numbers of all in-market monoclonal

antibodies in India, US and Europe.

Identifying the monoclonal antibodies that are patent protected in India, US and

Europe and those that are not

imarc© 2

Page 3: Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

Estimating the patent expiries of various monoclonal antibodies in India, US and

Europe.

Comprehensive situation analysis of the Indian therapeutic antibodies market

Analyzing current and future sales of monoclonal antibodies in India

Identifying all globally launched monoclonal antibodies and understanding their

performance and launch status in India

Analyzing the global and Indian monoclonal antibodies market by Indication

Evaluation of the top selling monoclonal antibodies

Key biosimilar antibody development programmes in India and abroad

imarc© 3

Page 4: Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

Table of Contents

1 Market Definitions & Methodology

2 Executive Summary

3 Indian Antibodies Market

4 Antibody Based Diagnostics Market in India

4.1 Industry Analysis4.1.1 Strengths4.1.2 Weaknesses4.1.3 Opportunities4.1.4 Threats

4.2 Technological & Regulatory Assessment4.2.1 Technological Assessment4.2.2 Regulatory Assessment

4.3 Market Analysis4.3.1 Current & Future Sales Trends4.3.2 Market Segments by Usage

4.3.2.1 HIV Diagnostics: Current Trends & Forecast4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast4.3.2.5 Dengue Diagnostics: Current Trends & Forecast4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast4.3.2.8 Oncology Diagnostics: Current Trends & Forecast

5 Therapeutic Antibodies Market in India

5.1 Industry Analysis5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats

5.2 Technological & Regulatory Assessment5.2.1 Technological Assessment5.2.2 Regulatory Assessment

5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India

5.4 Market Analysis5.4.1 Current & Future Sales Trends5.4.2 Sales Breakup by Molecule5.4.3 Sales by Indication

5.5 Evaluation of Top Monoclonal Antibodies5.5.1.1 Avastin5.5.1.2 Herceptin5.5.1.3 Rituxan/Mabthera5.5.1.4 Remicade5.5.1.5 Humira

5.6 Biosimilar Case Studies5.6.1 Reditux5.6.2 Grafeel

5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes

imarc© 4

Page 5: Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years

To buy the complete report or to get a free sample, please contact:

IMARC Group AsiaEmail: [email protected]: +91-120-425-6531

IMARC Group North America Email:  [email protected]: +1-631-791-1145

To know more please visit: http://www.imarcgroup.com/

Keywords: Indian antibodies market, Indian diagnostic market, Indian immunodiagnostics market, Indian immunology market, Indian monoclonal antibodies market, Indian biosimilar market,

imarc© 5

http://www.imarcgroup.com/

Guide to disrupting retail - DBS Bank · PDF fileprojected to grow at a CAGR ... non-store based retailing is projected to grow at a faster CAGR of ... Guide to disrupting retail

Australia Lip Balms Market to Grow with an Impressive CAGR until 2026

Immunodiagnostics for Leprosy

Clinical Chemistry and Immunodiagnostics Markets · Clinical Chemistry and Immunodiagnostics Markets ... Key issues of current chemistry and immunodiagnostic laboratory practice,

Global Immunodiagnostics Market 2017 - 2021

Kemira Capital Markets Day 2012: Appendix...expected to grow at 2-3% CAGR • Chemical demand from Asia Pasific region is expected to grow at CAGR of 4-5% from 2011 to 2020 • APAC

IR Company PresentationMarket by product type Number of systems IR Presentation, San Francisco, January 2018 CAGR 2016 - 2021: IVD Market: ~ 4-6% Molecular Diagnostic: ~ 8% Immunodiagnostics:

Global Frozen Food Market Is Expected To Grow At A CAGR Of

Introduction to immunodiagnostics and silent inflammation

Berenberg - STRATECir.stratec.com/stratec/pdf/pdf_id/440251.pdfPennyhill Park, December 7, 2016 CAGR 2013 - 2018: IVD Market: 4% Molecular Diagnostic: 8% Immunodiagnostics: 4% Hematology:

Energy storage market may grow at a CAGR of 8% till 2027